COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,001 Articles (22,627 medRxiv, 8,374 bioRxiv)

Most recent first Previous |  Page 1798: Articles 17971-17980  | Next

COVID-19 prevention behaviour over time in Australia: Patterns and long-term predictors from April to July 2020
Ayre, J., Cvejic, E., McCaffery, K. J., Copp, T., Cornell, S., Dodd, R. H., Pickles, K., Batcup, C., Isautier, J. M., Nickel, B., Dakin, T., Bonner, C.
10.1101/2021.02.04.21251165 — Posted: 2021-02-08
Assessment of Vaccination and Underreporting on COVID-19 Infections in Turkey Based On Effective Reproduction Number
Kose, E., Akman Yildiz, T., Tuncer, N.
10.1101/2021.02.04.21251176 — Posted: 2021-02-08
Introduction of a hand dermatitis clinic to reduce occupational dermatoses during the covid-19 pandemic.
Walsh, S., Carey, S.
10.1101/2021.02.04.21250767 — Posted: 2021-02-08
Longitudinal serology in SARS-CoV-2 infected individuals in India - a prospective cohort study
Thiruvengadam, R., Chattopadhyay, S., Mehdi, F., Desiraju, B. K., Chaudhuri, S., Singh, S., Bhartia, V., Kshetrapal, P., Natchu, U. C. M., Wadhwa, N., Sopory, S., Gosain, M., Pandey, A. K., Das, A., Anand, N., Sharma, N., Sharma, P., Saxena, S., Sindhu, D., Sindhu, B., Sharma, D., Dang, N., Batra, G., Kang, G., Bhatnagar, S., DBT India Consortium for COVID-19 Research
10.1101/2021.02.04.21251140 — Posted: 2021-02-08
Symptoms of COVID-19 infection and magnitude of antibody response in a large community-based study
McDade, T. W., Schrock, J., D'Aquila, R., Mustanski, B., Benbow, N., Vaught, L., Reiser, N., Velez, M., Hsieh, R., Ryan, D., Saber, R., MCNALLY, E., Demonbreun, A. R.
10.1101/2021.02.04.21251170 — Posted: 2021-02-08
Using Machine Learning to Predict Mortality for COVID-19 Patients on Day Zero in the ICU
Jamshidi, E., Asgary, A., Tavakoli, N., Zali, A., Esmaily, H., Jamaldini, S. H., Daaee, A., Babajani, A., Sendani Kashi, M. A., Jamshidi, M., Rahi, S., Mansouri, N.
10.1101/2021.02.04.21251131 — Posted: 2021-02-08
DrugWAS: Leveraging drug-wide association studies to facilitate drug repurposing for COVID-19
Bejan, C. A., Cahill, K. N., Staso, P. J., Choi, L., Peterson, J. F., Phillips, E. J.
10.1101/2021.02.04.21251169 — Posted: 2021-02-08
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
Ramakrishnan, S., Nicolau, D. V., Langford, B., Mahdi, M., Jeffers, H., Mwasuku, C., Krassowska, K., Fox, R., Binnian, I., Glover, V., Bright, S., Butler, C., Cane, J. L., Halner, A., Matthews, P. C., Donnelly, L. E., Simpson, J. L., Baker, J. R., Fadai, N. T., Peterson, S., Bengtsson, T., Barnes, P. J., Russell, R. E. K., Bafadhel, M.
10.1101/2021.02.04.21251134 — Posted: 2021-02-08 Discussion: Onsite | Offsite
SARS-CoV-2 Seroprevalence in Tamil Nadu in October-November 2020
Malani, A., Ramachandran, S., Tandel, V., Parasa, R., Sudharshini, S., Prakash, V., Yogananth, Y., Raju, S., Selvavinayagam, T. S.
10.1101/2021.02.03.21250949 — Posted: 2021-02-08
Emergence of SARS-CoV-2 stains harbouring the signature mutations of both A2a and A3 clade
Sarkar, R., Banerjee, D. A., Dutta, S., Chawla-Sarkar, D. M.
10.1101/2021.02.04.21251117 — Posted: 2021-02-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).